Extina foam (2%).
Abramovits
William
W
Baylor University Medical Center, Dallas, TX, USA.
Gupta
Aditya K
AK
D000279:Administration, Cutaneous; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004304:Dosage Forms; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D051381:Rats
D000935:Antifungal Agents; D004304:Dosage Forms; D007654:Ketoconazole